Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
HIV Clinical Trials|April 30, 2004
A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individualsSarah L Pett, Lisa A Williams, Richard O Day, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialFrank A Post, Alexander J Szubert, Andrew J Prendergast, et al.
Plos One|March 8, 2013
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studiesRichard T Davey, Ruth Lynfield, Dominic E Dwyer, et al.
Open Forum Infectious Diseases|June 25, 2026
Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway AnalysisKirstine K Rasmussen, Wendy Bannister, Theis Itenov, et al.
Contemporary Clinical Trials|May 31, 2025
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan AfricaFredrick Katongole, Tiyara Arumugam, Angus Jennings, et al.
Plos One|January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virusAminata Sy, Leanne McCabe, Emma Hudson, et al.
AIDS (London, England)|December 7, 2023
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIVAmelia E B Moore, James E Burns, Deirdre Sally, et al.
AIDS (London, England)|December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen statusSarah L Pett, Moira Spyer, Lewis J Haddow, et al.
The New England Journal of Medicine|July 21, 2017
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in AfricaJames Hakim, Victor Musiime, Alex J Szubert, et al.
Plos Medicine|December 5, 2018
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trialCissy Kityo, Alexander J Szubert, Abraham Siika, et al.
Pageof 6